IPASS: DATA FROM AN ONGOING STUDY OF THE TOLERABILITY AND EFFECTIVENESS OF INJECTABLE TESTOSTERONE UNDECANOATE FOR THE TREATMENT OF MALE HYPOGONADISM

被引：0
|
作者：
Zitzmann, M. [1 ]
Hanisch, J. U. [2 ]
Mattern, A. [3 ]
机构：
[1] Univ Clin Munster, Ctr Reprod Med & Androl, Munster, Germany
[2] Bayer Vital GmbH, Leverkusen, Germany
[3] Bayer Schering Pharma AG, Berlin, Germany
来源：
JOURNAL OF SEXUAL MEDICINE | 2010年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [41] Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data from an Ongoing Active Pharmacovigilance Study in Sicily
    Cicala, G.
    Barbieri, M. A.
    Santoro, V.
    Gagliano, A.
    Germano, E.
    Tata, C.
    Colucci, V.
    Vanadia, F.
    Drago, F.
    Russo, C.
    Cutroneo, P. M.
    Spina, E.
    DRUG SAFETY, 2018, 41 (11) : 1164 - 1164
  • [42] Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study
    Hackett, Geoffrey
    Cole, Nigel
    Saghir, Atif
    Jones, Peter
    Strange, Richards C.
    Ramachandran, Sudarshan
    BJU INTERNATIONAL, 2016, 118 (05) : 804 - 813
  • [43] THE EFFECTS OF INTRANASAL TESTOSTERONE (NATESTO™) FOR TREATMENT OF HYPOGONADISM ON MAINTENANCE OF SPERMATOGENESIS: DEMOGRAPHIC DATA FROM A SINGLE-INSTITUTION, PROSPECTIVE, NON-BLINDED STUDY
    Campbell, K.
    Potts, S.
    Hernandezl, A.
    Bacchus, M.
    Lipshultz, L.
    JOURNAL OF SEXUAL MEDICINE, 2023, 20
  • [44] PREDIABETES, HYPOGONADISM & ERECTILE DYSFUNCTION: GLYCAEMIC CONTROL IN 109 HYPOGONADAL MEN TREATED WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) FOR UP TO 8 YEARS: REAL-LIFE DATA FROM REGISTRY STUDIES
    Yassin, Aksam
    Haider, Ahmad
    Haider, Karim
    Doros, Gheorghe
    Traish, Abdulmaged
    Saad, Farid
    JOURNAL OF UROLOGY, 2016, 195 (04): : E629 - E629
  • [45] Obese hypogonadal men with a history of cardiovascular diseases (CVD) benefit from long-term treatment with testosterone undecanoate (TU): observational, real-life data from a registry study
    Saad, F.
    Haider, A.
    Haider, K. S.
    Doros, G.
    Traish, A.
    EUROPEAN HEART JOURNAL, 2015, 36 : 474 - 474
  • [46] Assessing effectiveness in the presence of treatment switching: Data from an effectiveness study of antipsychotics
    Faries, D
    Nyhuis, A
    Tunis, SL
    Hernan, M
    VALUE IN HEALTH, 2004, 7 (03) : 231 - 232
  • [47] Characteristics of patients newly initiating a preventive treatment for migraine: Baseline data from the Assessment of TolerabiliTy and Effectiveness in MigrAINeurs using Preventive Treatment (ATTAIN) study
    Kawata, Ariane K.
    Shah, Neel
    Poon, Jiat-Ling
    Shaffer, Shannon
    Sapra, Sandhya
    Mutebi, Alex
    Wilcox, Teresa K.
    Tepper, Stewart J.
    Dodick, David W.
    Lipton, Richard B.
    CEPHALALGIA, 2017, 37 : 273 - 274
  • [48] Treatment with Testosterone Undecanoate Injections (TU) Results in Marked Weight Loss That Is Maintained Long Term in Men with Hypogonadism and Type 2 Diabetes (T2DM): Update of Real-World Data from a Urological Practice
    Haider, Ahmad
    Haider, Karim S.
    Saad, Farid
    DIABETES, 2020, 69
  • [49] POSITIVE EFFECTS OF LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) ON RENAL FUNCTION IN HYPOGONADAL MEN: REAL-LIFE DATA FROM A PROSPECTIVE CONTROLLED REGISTRY STUDY
    Yassin, Aksam
    Yassin, Dany-Jan
    Doros, Gheorge
    Traish, Abdulmaged
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1222 - E1222
  • [50] Cost-effectiveness of testosterone treatment utilising individual patient data from randomised controlled trials in men with low testosterone levels
    Hernandez, Rodolfo
    de Silva, Nipun Lakshitha
    Hudson, Jemma
    Cruickshank, Moira
    Quinton, Richard
    Manson, Paul
    Dhillo, Waljit S.
    Bhattacharya, Siladitya
    Brazzelli, Miriam
    Jayasena, Channa N.
    ANDROLOGY, 2024, 12 (03) : 477 - 486
12345